NEOVACS (ALNEV.PA)

FR001400TG47 - Common Stock

0.93  -0.07 (-6.95%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
22.54K
-24.31%		1.11K
-95.08%		533.41K
47,954.95%
EBITDA
YoY % growth
N/A-5.978M-1.889M
68.40%
EBIT
YoY % growth
-7.828M
-124.18%		-6.445M
17.67%		-6.908M
-7.18%
Operating Margin
-34,728.75%-580,627.93%-1,294.98%
EPS
YoY % growth
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 250.26K
144.47%		%
Q4 2023
Q2Q % growth		 431.04K
38,732.43%		%
Q2 2023
Q2Q % growth		 102.37K
104.74%		%
Q4 2022
Q2Q % growth		 1.11K
-95.08%		%
Q2 2022
Q2Q % growth		 50K
-16.07%		%
Q4 2021
Q2Q % growth		 22.54K
-24.31%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A